Vincent S. Stoll

Publications by Year

Research Areas

HIV/AIDS drug development and treatment, Synthesis and biological activity, PI3K/AKT/mTOR signaling in cancer, Enzyme Structure and Function, Click Chemistry and Applications

Most-Cited Works

• → [4] Buffers: Principles and practice(1990)252 cited
• → Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo(2005)244 cited
• → Discovery ofN-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor(2007)184 cited
• → Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors(2005)152 cited
• → Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series(2003)128 cited
• → Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro(2005)120 cited
• → X-ray crystallographic structure of ABT-378 (Lopinavir) bound to HIV-1 protease(2002)99 cited
• → Discovery of 3H-Benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM) Kinases(2009)84 cited
• → Discovery and Characterization of Non-ATP Site Inhibitors of the Mitogen Activated Protein (MAP) Kinases(2010)80 cited
• → Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activity(2005)73 cited